Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection.

Journal of virology - 1 Sept 2003

Weinberger Leor S, Schaffer David V, Arkin Adam P

Abstract excerpt

Recent reports confirm that, due to the presence of long-lived, latently infected cell populations, eradication of human immunodeficiency virus type 1 (HIV-1) from infected patients by using antiretroviral drugs will be exceedingly difficult. An alternative to virus eradication may be to use gene therapy to induce a pseudo-latent state in virus-producing cells, thus transforming HIV-1 into a lifelong, but...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Research and Treatment

Share to Mathematics

Share to Models, Theoretical

Share to Mutation

Share to Recombination, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 12941913
DOI: 10.1128/jvi.77.18.10028-10036.2003
PMCID: PMC224590

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection.PMID 12941913Read ↗

Evolutionary analysis of human immunodeficiency virus type 1 therapies based on conditionally replicating vectors.Semantic proximity Read ↗

Precision Elimination: Proof-of-Concept In Silico Testing of a Novel Construct for Optimizing HIV-1 EradicationSemantic proximity Read ↗

Autonomous targeting of infectious superspreaders using engineered transmissible therapies.Semantic proximity Read ↗

Targeting HIV at its core: A mathematical model for optimizing Tat Inhibitor-based therapies toward enhanced functional cure strategiesSemantic proximity Read ↗

A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In VivoSemantic proximity Read ↗

Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles.Semantic proximity Read ↗

Computational Design of Antiviral RNA Interference Strategies That Resist Human Immunodeficiency Virus EscapeSemantic proximity Read ↗

Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads.Semantic proximity Read ↗

Engineering T Cells to Functionally Cure HIV-1 InfectionSemantic proximity Read ↗

A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.Semantic proximity Read ↗

Discovery and Engineering of a Therapeutic Interfering Particle (TIP): a combination self-renewing antiviralSemantic proximity Read ↗

Gene therapy approaches to functional cure and protection of hematopoietic potential in HIV infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.